Skip to content

Added to your cart:

Cart subtotal

View cart (2) Checkout
Best Selling Products Corticosteroid Shots, Steroid Injections Corticosteroids Injections, Prefilled Syringes and Topical Ointments Injectable Medications IV Bags, IV Sets and Injection Medication Vials Osteoarthritis Relief Products Prescription Drugs and Prescription Medications Prescription Medications & Prescription Drugs Sports Medicine Pain Relief Products Triamcinolone Acetonide Creams, Ointments and Injections Inflammatory Bowel Disease Medications Epidural Medications Amneal Pharmaceutical Products Medical Supplies for Bulk Ordering by Clinics, EMS, and Distributors Rheumatoid Arthritis Relief Products

Filters

Availability
Price
$
-
$
$0 $159
Vendor
Collection
Tags

Kenalog Injections

Kenalog Injections

Kenalog is the brand name for triamcinolone acetonide injectable suspension – a potent glucocorticoid (corticosteroid) given by healthcare providers. It is used to suppress inflammation and immune reactions, replacing or augmenting the body’s own steroid production. Triamcinolone works by altering immune system responses and reducing swelling, redness, heat, and pain. It comes as an aqueous suspension that is injected intramuscularly, intra-articularly (into joints), or intralesionally (into skin lesions) depending on the formulation. Kenalog injections are long-acting (depot) steroids, so the drug is released slowly at the injection site to provide sustained anti-inflammatory effect.

Kenalog Injection (triamcinolone acetonide) is a prescription corticosteroid (steroid) medication given by injection. Each Kenalog injection contains triamcinolone acetonide (e.g. 40 mg/mL). It is used as a powerful anti-inflammatory/immunosuppressive treatment in many conditions. For example, Kenalog injections are given into joints or muscles to relieve inflammation, pain and swelling from disorders like rheumatoid arthritis, osteoarthritis, bursitis, tendonitis, and other joint/tendon inflammations. It is also used for severe allergic or dermatologic conditions – for instance, acute asthma exacerbations, severe allergies, or inflammatory skin diseases – when injected intramuscularly or into affected sites. Essentially, Kenalog injection provides a concentrated dose of steroid to a localized area or systemically, reducing immune activity and inflammation under medical supervision.

Formulations and Strengths: Kenalog is available mainly in two strengths: 10 mg/mL and 40 mg/mL suspensions. The 10 mg/mL suspension (Kenalog-10) contains triamcinolone 10 mg/mL with benzyl alcohol preservative, and is labeled for intra-articular (joint) or intralesional use only. The 40 mg/mL suspension (Kenalog-40) contains triamcinolone 40 mg/mL (also with benzyl alcohol) and is labeled for intra-articular or intramuscular use. (An 80 mg/mL form also exists but is less commonly used.) Importantly, Kenalog-10 should never be given IM, and Kenalog-40/80 should not be injected into the skin (intradermal). Kenalog suspensions are thick and must be shaken vigorously before drawing up (the crystals settle over time). Each vial or syringe should be inspected for clumping or discoloration before use – do not use if it appears frozen or agglomerated.

Key Indications (Uses): Because triamcinolone is a broad anti-inflammatory steroid, Kenalog injections have many applications. They are used whenever a depot steroid is needed and other routes (like oral) are impractical or too slow. Typical uses include:

  • Joint and Soft-Tissue Inflammation: Kenalog injections are used into inflamed joints or tendon sheaths to relieve pain and swelling from arthritis or tendonitis. Examples: rheumatoid arthritis flares, osteoarthritis synovitis, gouty arthritis, acute bursitis, tenosynovitis (e.g. De Quervain’s), and epicondylitis (tennis elbow). In these cases, the steroid is injected directly into the affected joint or bursa (intra-articular injection) to get a powerful local effect. Kenalog can rapidly reduce inflammation in acute flares when applied this way. Example: Acute gouty arthritis of the knee or big toe is often treated on the spot with an intra-articular Kenalog injection.

  • Dermatologic (Intralesional) Conditions: Kenalog can be injected into the skin (intradermally or subcutaneously) for certain skin lesions. Kenalog-10 is commonly used for intralesional therapy in conditions like keloid or hypertrophic scar treatment, alopecia areata patches, lichen planus, psoriasis plaques, granuloma annulare, and other localized dermopathies. Very small volumes (often 0.1–0.5 mL containing 1–5 mg steroid) are injected directly into each lesion or scar, typically weekly or spaced out, to reduce inflammation and abnormal tissue growth.

  • Systemic Allergic/Inflammatory Conditions (IM use): Kenalog-40 given intramuscularly is used when low-potency oral steroids are not suitable or rapid effect is needed. Indications include severe asthma or allergic reactions (e.g. intractable asthma exacerbations, severe atopic or contact dermatitis) that have not responded to standard treatments. It is also used for certain autoimmune or allergic hematologic conditions (e.g. ITP, hemolytic anemia), acute inflammatory bowel disease flares (Crohn’s colitis, ulcerative colitis), and neurologic emergencies like multiple sclerosis exacerbations or cerebral edema. Essentially, any acute systemic inflammatory condition (rheumatic, dermatologic, endocrine crisis, or neoplastic) in which an injectable steroid is needed can be an indication. (For example, when oral prednisone is not possible or safe, a single IM Kenalog shot of 40–60 mg can be given.) Kenalog-40 can also be used for seasonal allergic triggers (some providers give one Kenalog injection per allergy season to prevent exacerbations).

(Note: Kenalog is not a substitute for emergency anaphylaxis treatment. Use epinephrine immediately for anaphylaxis. Kenalog IM is sometimes given after an initial allergic reaction to extend anti-inflammatory coverage, but it is not a rescue for airway obstruction.)

Dosage and Strength Selection: The dose and choice of strength depend on the route and target site:

  • Small vs. Large Joints: For intra-articular injections, Kenalog-10 and Kenalog-40 can both be used, but amounts differ. As a rule of thumb:

    • Large joints (knee, shoulder, hip): use Kenalog-40 with 15–40 mg (0.375–1 mL of 40 mg/mL). Kenalog-10 could be used instead (5–15 mg; 0.5–1.5 mL), but 40 mg/mL is often chosen for larger volumes liver.
    • Small joints (wrist, elbow, foot joints, small hand joints): use Kenalog-40 with 2.5–10 mg (0.06–0.25 mL of 40 mg/mL), or Kenalog-10 with 2.5–5 mg (0.25–0.5 mL). Multiple small joints may be injected separately up to a total of ~20 mg steroid.
    • Tendon sheaths/bursae: doses similar to small joints (typically 10–20 mg Kenalog-40 or 5–10 mg Kenalog-10).

  • Intralesional (Dermal) Use: Use Kenalog-10 mg/mL. Individual lesions typically receive only 0.1–0.5 mL (1–5 mg steroid) at each injection point. Injections are repeated (e.g. weekly or biweekly) until the lesion improves, with care to keep injections at least ~1 cm apart to prevent skin atrophy. Avoid injecting large volumes in one area – the goal is localized effect.

  • Intramuscular (IM) Use: Use Kenalog-40 mg/mL. Common adult doses for IM therapy are on the order of 20–60 mg (i.e. 0.5–1.5 mL of 40 mg/mL) as a single shot. For example, treating a severe allergic asthma flare might involve 40–60 mg IM once. Higher total doses (e.g. 60–80 mg) can be given in extremely severe cases or systemic disease, but usually 40 mg is enough for most acute flares. IM injections may be repeated after several days or weeks if clinically needed, but avoid frequent repeats without taper – HPA axis suppression is a concern. In pediatrics, dosages are weight-based (often 0.1–0.2 mg/kg IM).

In summary: Use Kenalog-10 for targeted joint or skin injections in smaller amounts; use Kenalog-40 for larger joint injections or systemic (IM) injections requiring a higher dose. Always individualize the dose to the patient’s size, joint size, and disease severity.

Injection Technique:

  • General Preparation: Use strict aseptic technique. Shake the Kenalog vial vigorously and ensure a uniform milky suspension before drawing up. Inspect the suspension for clumping or discoloration – do not use it if it looks frozen or separated. Use a clean syringe and needle (Kenalog suspensions are thick; a larger gauge like 18–22G may be needed to draw it up, though a finer gauge can be used for injection if desired). Withdraw the prescribed dose promptly and inject without long delay (to prevent settling). Expel air bubbles from the syringe.

  • Intramuscular Injection: Kenalog-40 (40 mg/mL) is given IM. Have the patient relax the muscle (e.g. sit or lie properly). Common sites: upper outer gluteal or lateral thigh (ventrogluteal), or deltoid muscle (for smaller volumes). Clean the skin with antiseptic. Insert the needle fully into muscle at 90°, aspirate briefly (standard IM practice) to ensure not in a vessel, then inject slowly. No need to massage or aspirate fluid afterward. Be aware that Kenalog-40 contains benzyl alcohol, so it may sting; inject gently. After injection, apply gentle pressure and a bandage. (For pediatric IM injections, Kenalog should be avoided in newborns due to benzyl alcohol, which can cause toxicity.)

  • Intra-Articular (Joint) Injection: Choose the correct anatomical site for the joint. For large joints (like knee, shoulder, hip), standardized injection approaches exist (e.g. knee: anterolateral or superolateral approach). Prep the skin with antiseptic. If the joint is effused, you may first aspirate synovial fluid (to relieve pressure and avoid diluting the steroid). It is often helpful to inject a small amount (1–3 mL) of anesthetic (like lidocaine 0.5–1%) into the joint first for patient comfort. Then inject the Kenalog dose slowly into the joint space. Important: advance the needle into the true joint space – aspirate gently again for a little synovial fluid to confirm placement if possible. Be careful not to inject Kenalog into surrounding soft tissue or subcutaneous layer, as this may cause fat atrophy or skin discoloration. Injecting directly into tendon sheaths or bursae (e.g. for epicondylitis or subacromial bursitis) uses a similar sterile technique. After injection, flex and extend the joint a few times to disperse the steroid.

  • Intralesional (Dermal) Injection: Use Kenalog-10 in a tuberculin syringe (1 mL syringe) with a fine needle (23–25 gauge). Clean the lesion. Insert the needle bevel-up into the dermis of the lesion. Gradually inject a small volume to form a bleb or wheal in the lesion. For example, injecting a keloid: advance along the lesion length, injecting 0.1–0.3 mL per spot. Multiple small injections may be given along the lesion. Limit to about 1 mg/site (0.1 mL) for small lesions to avoid high local concentration. Keep injection sites at least ~1 cm apart. Consider using a topical anesthetic or cold spray (ethyl chloride) to numb the skin beforehand, as these injections can hurt. Afterward, apply a small bandage.

  • Always label/record: Document the site, dose, and lot number after injection. If more than one ampule/vial is used, record each lot.

Monitoring & Safety: Kenalog is a powerful steroid, so vigilance is required:

  • Vital Signs & Immediate Reaction: Although systemic absorption is slower, monitor briefly for any acute allergic reaction at the injection time. (Severe reaction to steroids is rare, but observe for a few minutes.)

  • Local Site: Check the injection site over the next day for excessive swelling, pain, redness, or infection.

  • Systemic Effects: Inform patients (or watch for) symptoms like flushing, insomnia, mood changes, increased appetite, or hyperglycemia after the injection. Steroids can raise blood sugar; monitor diabetic patients. They may need more insulin temporarily. Also watch blood pressure and edema especially in susceptible patients.

  • Repeated Injections: Track cumulative steroid dosing. Repeated Kenalog injections can suppress the hypothalamic-pituitary-adrenal (HPA) axis, potentially causing adrenal insufficiency if steroids are stopped abruptly. For example, if giving monthly intra-articular shots, plan to taper or allow the body time to recover between courses. If a patient has received chronic oral steroids, giving a large Kenalog dose may precipitate HPA suppression. Always consider “steroid stacking.”

  • Infection: Never inject if there is an active infection at the site or systemic infection without antibiotics. Corticosteroids can mask infection signs. A septic joint requires antibiotics, not steroid, unless infection is cleared.

  • Contraindications: Known allergy to triamcinolone or any preservative. Not for IV use, not for epidural/intrathecal or intraocular injection (these routes have caused fatal outcomes). Kenalog-10 is not for IM use, and Kenalog-40 is not to be used intradermally. Avoid in neonates (benzyl alcohol in Kenalog can cause “gasping syndrome” in infants).

  • Other Precautions: Screen for diabetes, osteoporosis, glaucoma, hypertension, peptic ulcer disease, etc. – these conditions can worsen with steroids. Ensure no live vaccines are due (live vaccines should be deferred while on high-dose steroids and up to ~4 weeks after). Steroids can increase risk for steroid acne or fungal infections; treat those if they appear.

Helpful Tips for Providers:

  • Drawing up the drug: Kenalog suspension can be viscous. Use a clean needle and syringe, and draw slowly. Change to a finer needle after drawing if preferred for injection (especially for intradermal use).

  • Shake the vial: Always mix well just before withdrawing dose. Failure to resuspend can give a sub-therapeutic dose.

  • Avoid air emboli: Before injection, tap air bubbles out thoroughly. Small air bubbles are not a big issue in joints or muscle, but larger air globules should be removed.

  • Dose Verification: Have another caregiver double-check the dose and site (especially if giving high systemic dose IM).

  • Post-Injection Care: Advise the patient to rest the treated joint for 24 hours and apply ice to reduce pain/swelling. The steroid effect usually begins in 1–3 days and peaks by 1–2 weeks. Tell the patient to report if pain or swelling worsens, or if signs of infection develop.

  • Documentation: Record the dose, site, lot numbers, and patient’s response. Write “Kenalog 10 mg/mL” or “40 mg/mL” clearly on the chart. (Nurse charts and floor stocks often have similar-sounding names – be precise.)

  • Storage: Store Kenalog vials at room temperature, away from freezing. Do not use if expired or stored improperly.

  • Education: Inform patients that Kenalog injections may cause transient discomfort. They should report symptoms like severe weakness, vision changes, or vomiting, which could indicate adrenal suppression (rare with single dose but possible with repeated doses).

Summary: Kenalog injections are a versatile, long-acting corticosteroid therapy used for localized or systemic inflammatory conditions. Kenalog-10 (10 mg/mL) is used for intra-articular or intralesional injections, and Kenalog-40 (40 mg/mL) for larger joint or intramuscular injections. Proper injection technique and monitoring are crucial. Providers should shake the suspension, use aseptic technique, and inject into the correct tissue (joint vs. muscle vs. skin) to maximize benefit and minimize complications. Patients benefit from rapid relief of inflammation, but providers must watch for systemic steroid effects (e.g. hyperglycemia, HPA suppression) and ensure safe intervals between doses

Most Common Conditions Treated With Kenalog Injections

  • Osteoarthritis, Rheumatoid Arthritis, and Gout
  • Bursitis and Tendonitis
  • Frozen Shoulder & Joint Capsule Inflammation
  • Carpal Tunnel Syndrome and Plantar Fasciitis
  • Chronic Back, Neck, or Sciatic Nerve Pain
  • Allergic Reactions (Severe Hay Fever, Asthma Flare-Ups)
  • Psoriasis, Eczema, and Other Skin Disorders
  • Keloid and Hypertrophic Scar Reduction

Kenalog injection is an injectable form of the corticosteroid triamcinolone (brand Kenalog). It is used by doctors to quickly dampen severe inflammation or allergic reactions in joints, skin, respiratory tract, and other tissues. It’s a prescription medication given by needle, not a home-use product.

People Also Searched For

Kenalog Injections by Bristol Myers Squibb Kenalog Injections to doctor-only Kenalog Injections to Kenalog Kenalog Injections to Triamcinolone Acetonide Kenalog Injections to Corticosteroids Kenalog Injections to Kenalog Shot Kenalog Injections to Corticosteroid Corticosteroid Shots, Steroid Injections Triamcinolone Acetonide Creams, Ointments and Injections Corticosteroids Injections, Prefilled Syringes and Topical Ointments

Kenalog Injections

Kenalog is the brand name for triamcinolone acetonide injectable suspension – a potent glucocorticoid (corticosteroid) given by healthcare providers. It is used to suppress inflammation and immune reactions, replacing or augmenting the body’s own steroid production. Triamcinolone works by altering immune system responses and reducing swelling, redness, heat, and pain. It comes as an aqueous suspension that is injected intramuscularly, intra-articularly (into joints), or intralesionally (into skin lesions) depending on the formulation. Kenalog injections are long-acting (depot) steroids, so the drug is released slowly at the injection site to provide sustained anti-inflammatory effect.

Kenalog Injection (triamcinolone acetonide) is a prescription corticosteroid (steroid) medication given by injection. Each Kenalog injection contains triamcinolone acetonide (e.g. 40 mg/mL). It is used as a powerful anti-inflammatory/immunosuppressive treatment in many conditions. For example, Kenalog injections are given into joints or muscles to relieve inflammation, pain and swelling from disorders like rheumatoid arthritis, osteoarthritis, bursitis, tendonitis, and other joint/tendon inflammations. It is also used for severe allergic or dermatologic conditions – for instance, acute asthma exacerbations, severe allergies, or inflammatory skin diseases – when injected intramuscularly or into affected sites. Essentially, Kenalog injection provides a concentrated dose of steroid to a localized area or systemically, reducing immune activity and inflammation under medical supervision.

Formulations and Strengths: Kenalog is available mainly in two strengths: 10 mg/mL and 40 mg/mL suspensions. The 10 mg/mL suspension (Kenalog-10) contains triamcinolone 10 mg/mL with benzyl alcohol preservative, and is labeled for intra-articular (joint) or intralesional use only. The 40 mg/mL suspension (Kenalog-40) contains triamcinolone 40 mg/mL (also with benzyl alcohol) and is labeled for intra-articular or intramuscular use. (An 80 mg/mL form also exists but is less commonly used.) Importantly, Kenalog-10 should never be given IM, and Kenalog-40/80 should not be injected into the skin (intradermal). Kenalog suspensions are thick and must be shaken vigorously before drawing up (the crystals settle over time). Each vial or syringe should be inspected for clumping or discoloration before use – do not use if it appears frozen or agglomerated.

Key Indications (Uses): Because triamcinolone is a broad anti-inflammatory steroid, Kenalog injections have many applications. They are used whenever a depot steroid is needed and other routes (like oral) are impractical or too slow. Typical uses include:

  • Joint and Soft-Tissue Inflammation: Kenalog injections are used into inflamed joints or tendon sheaths to relieve pain and swelling from arthritis or tendonitis. Examples: rheumatoid arthritis flares, osteoarthritis synovitis, gouty arthritis, acute bursitis, tenosynovitis (e.g. De Quervain’s), and epicondylitis (tennis elbow). In these cases, the steroid is injected directly into the affected joint or bursa (intra-articular injection) to get a powerful local effect. Kenalog can rapidly reduce inflammation in acute flares when applied this way. Example: Acute gouty arthritis of the knee or big toe is often treated on the spot with an intra-articular Kenalog injection.

  • Dermatologic (Intralesional) Conditions: Kenalog can be injected into the skin (intradermally or subcutaneously) for certain skin lesions. Kenalog-10 is commonly used for intralesional therapy in conditions like keloid or hypertrophic scar treatment, alopecia areata patches, lichen planus, psoriasis plaques, granuloma annulare, and other localized dermopathies. Very small volumes (often 0.1–0.5 mL containing 1–5 mg steroid) are injected directly into each lesion or scar, typically weekly or spaced out, to reduce inflammation and abnormal tissue growth.

  • Systemic Allergic/Inflammatory Conditions (IM use): Kenalog-40 given intramuscularly is used when low-potency oral steroids are not suitable or rapid effect is needed. Indications include severe asthma or allergic reactions (e.g. intractable asthma exacerbations, severe atopic or contact dermatitis) that have not responded to standard treatments. It is also used for certain autoimmune or allergic hematologic conditions (e.g. ITP, hemolytic anemia), acute inflammatory bowel disease flares (Crohn’s colitis, ulcerative colitis), and neurologic emergencies like multiple sclerosis exacerbations or cerebral edema. Essentially, any acute systemic inflammatory condition (rheumatic, dermatologic, endocrine crisis, or neoplastic) in which an injectable steroid is needed can be an indication. (For example, when oral prednisone is not possible or safe, a single IM Kenalog shot of 40–60 mg can be given.) Kenalog-40 can also be used for seasonal allergic triggers (some providers give one Kenalog injection per allergy season to prevent exacerbations).

(Note: Kenalog is not a substitute for emergency anaphylaxis treatment. Use epinephrine immediately for anaphylaxis. Kenalog IM is sometimes given after an initial allergic reaction to extend anti-inflammatory coverage, but it is not a rescue for airway obstruction.)

Dosage and Strength Selection: The dose and choice of strength depend on the route and target site:

  • Small vs. Large Joints: For intra-articular injections, Kenalog-10 and Kenalog-40 can both be used, but amounts differ. As a rule of thumb:

    • Large joints (knee, shoulder, hip): use Kenalog-40 with 15–40 mg (0.375–1 mL of 40 mg/mL). Kenalog-10 could be used instead (5–15 mg; 0.5–1.5 mL), but 40 mg/mL is often chosen for larger volumes liver.
    • Small joints (wrist, elbow, foot joints, small hand joints): use Kenalog-40 with 2.5–10 mg (0.06–0.25 mL of 40 mg/mL), or Kenalog-10 with 2.5–5 mg (0.25–0.5 mL). Multiple small joints may be injected separately up to a total of ~20 mg steroid.
    • Tendon sheaths/bursae: doses similar to small joints (typically 10–20 mg Kenalog-40 or 5–10 mg Kenalog-10).

  • Intralesional (Dermal) Use: Use Kenalog-10 mg/mL. Individual lesions typically receive only 0.1–0.5 mL (1–5 mg steroid) at each injection point. Injections are repeated (e.g. weekly or biweekly) until the lesion improves, with care to keep injections at least ~1 cm apart to prevent skin atrophy. Avoid injecting large volumes in one area – the goal is localized effect.

  • Intramuscular (IM) Use: Use Kenalog-40 mg/mL. Common adult doses for IM therapy are on the order of 20–60 mg (i.e. 0.5–1.5 mL of 40 mg/mL) as a single shot. For example, treating a severe allergic asthma flare might involve 40–60 mg IM once. Higher total doses (e.g. 60–80 mg) can be given in extremely severe cases or systemic disease, but usually 40 mg is enough for most acute flares. IM injections may be repeated after several days or weeks if clinically needed, but avoid frequent repeats without taper – HPA axis suppression is a concern. In pediatrics, dosages are weight-based (often 0.1–0.2 mg/kg IM).

In summary: Use Kenalog-10 for targeted joint or skin injections in smaller amounts; use Kenalog-40 for larger joint injections or systemic (IM) injections requiring a higher dose. Always individualize the dose to the patient’s size, joint size, and disease severity.

Injection Technique:

  • General Preparation: Use strict aseptic technique. Shake the Kenalog vial vigorously and ensure a uniform milky suspension before drawing up. Inspect the suspension for clumping or discoloration – do not use it if it looks frozen or separated. Use a clean syringe and needle (Kenalog suspensions are thick; a larger gauge like 18–22G may be needed to draw it up, though a finer gauge can be used for injection if desired). Withdraw the prescribed dose promptly and inject without long delay (to prevent settling). Expel air bubbles from the syringe.

  • Intramuscular Injection: Kenalog-40 (40 mg/mL) is given IM. Have the patient relax the muscle (e.g. sit or lie properly). Common sites: upper outer gluteal or lateral thigh (ventrogluteal), or deltoid muscle (for smaller volumes). Clean the skin with antiseptic. Insert the needle fully into muscle at 90°, aspirate briefly (standard IM practice) to ensure not in a vessel, then inject slowly. No need to massage or aspirate fluid afterward. Be aware that Kenalog-40 contains benzyl alcohol, so it may sting; inject gently. After injection, apply gentle pressure and a bandage. (For pediatric IM injections, Kenalog should be avoided in newborns due to benzyl alcohol, which can cause toxicity.)

  • Intra-Articular (Joint) Injection: Choose the correct anatomical site for the joint. For large joints (like knee, shoulder, hip), standardized injection approaches exist (e.g. knee: anterolateral or superolateral approach). Prep the skin with antiseptic. If the joint is effused, you may first aspirate synovial fluid (to relieve pressure and avoid diluting the steroid). It is often helpful to inject a small amount (1–3 mL) of anesthetic (like lidocaine 0.5–1%) into the joint first for patient comfort. Then inject the Kenalog dose slowly into the joint space. Important: advance the needle into the true joint space – aspirate gently again for a little synovial fluid to confirm placement if possible. Be careful not to inject Kenalog into surrounding soft tissue or subcutaneous layer, as this may cause fat atrophy or skin discoloration. Injecting directly into tendon sheaths or bursae (e.g. for epicondylitis or subacromial bursitis) uses a similar sterile technique. After injection, flex and extend the joint a few times to disperse the steroid.

  • Intralesional (Dermal) Injection: Use Kenalog-10 in a tuberculin syringe (1 mL syringe) with a fine needle (23–25 gauge). Clean the lesion. Insert the needle bevel-up into the dermis of the lesion. Gradually inject a small volume to form a bleb or wheal in the lesion. For example, injecting a keloid: advance along the lesion length, injecting 0.1–0.3 mL per spot. Multiple small injections may be given along the lesion. Limit to about 1 mg/site (0.1 mL) for small lesions to avoid high local concentration. Keep injection sites at least ~1 cm apart. Consider using a topical anesthetic or cold spray (ethyl chloride) to numb the skin beforehand, as these injections can hurt. Afterward, apply a small bandage.

  • Always label/record: Document the site, dose, and lot number after injection. If more than one ampule/vial is used, record each lot.

Monitoring & Safety: Kenalog is a powerful steroid, so vigilance is required:

  • Vital Signs & Immediate Reaction: Although systemic absorption is slower, monitor briefly for any acute allergic reaction at the injection time. (Severe reaction to steroids is rare, but observe for a few minutes.)

  • Local Site: Check the injection site over the next day for excessive swelling, pain, redness, or infection.

  • Systemic Effects: Inform patients (or watch for) symptoms like flushing, insomnia, mood changes, increased appetite, or hyperglycemia after the injection. Steroids can raise blood sugar; monitor diabetic patients. They may need more insulin temporarily. Also watch blood pressure and edema especially in susceptible patients.

  • Repeated Injections: Track cumulative steroid dosing. Repeated Kenalog injections can suppress the hypothalamic-pituitary-adrenal (HPA) axis, potentially causing adrenal insufficiency if steroids are stopped abruptly. For example, if giving monthly intra-articular shots, plan to taper or allow the body time to recover between courses. If a patient has received chronic oral steroids, giving a large Kenalog dose may precipitate HPA suppression. Always consider “steroid stacking.”

  • Infection: Never inject if there is an active infection at the site or systemic infection without antibiotics. Corticosteroids can mask infection signs. A septic joint requires antibiotics, not steroid, unless infection is cleared.

  • Contraindications: Known allergy to triamcinolone or any preservative. Not for IV use, not for epidural/intrathecal or intraocular injection (these routes have caused fatal outcomes). Kenalog-10 is not for IM use, and Kenalog-40 is not to be used intradermally. Avoid in neonates (benzyl alcohol in Kenalog can cause “gasping syndrome” in infants).

  • Other Precautions: Screen for diabetes, osteoporosis, glaucoma, hypertension, peptic ulcer disease, etc. – these conditions can worsen with steroids. Ensure no live vaccines are due (live vaccines should be deferred while on high-dose steroids and up to ~4 weeks after). Steroids can increase risk for steroid acne or fungal infections; treat those if they appear.

Helpful Tips for Providers:

  • Drawing up the drug: Kenalog suspension can be viscous. Use a clean needle and syringe, and draw slowly. Change to a finer needle after drawing if preferred for injection (especially for intradermal use).

  • Shake the vial: Always mix well just before withdrawing dose. Failure to resuspend can give a sub-therapeutic dose.

  • Avoid air emboli: Before injection, tap air bubbles out thoroughly. Small air bubbles are not a big issue in joints or muscle, but larger air globules should be removed.

  • Dose Verification: Have another caregiver double-check the dose and site (especially if giving high systemic dose IM).

  • Post-Injection Care: Advise the patient to rest the treated joint for 24 hours and apply ice to reduce pain/swelling. The steroid effect usually begins in 1–3 days and peaks by 1–2 weeks. Tell the patient to report if pain or swelling worsens, or if signs of infection develop.

  • Documentation: Record the dose, site, lot numbers, and patient’s response. Write “Kenalog 10 mg/mL” or “40 mg/mL” clearly on the chart. (Nurse charts and floor stocks often have similar-sounding names – be precise.)

  • Storage: Store Kenalog vials at room temperature, away from freezing. Do not use if expired or stored improperly.

  • Education: Inform patients that Kenalog injections may cause transient discomfort. They should report symptoms like severe weakness, vision changes, or vomiting, which could indicate adrenal suppression (rare with single dose but possible with repeated doses).

Summary: Kenalog injections are a versatile, long-acting corticosteroid therapy used for localized or systemic inflammatory conditions. Kenalog-10 (10 mg/mL) is used for intra-articular or intralesional injections, and Kenalog-40 (40 mg/mL) for larger joint or intramuscular injections. Proper injection technique and monitoring are crucial. Providers should shake the suspension, use aseptic technique, and inject into the correct tissue (joint vs. muscle vs. skin) to maximize benefit and minimize complications. Patients benefit from rapid relief of inflammation, but providers must watch for systemic steroid effects (e.g. hyperglycemia, HPA suppression) and ensure safe intervals between doses

Most Common Conditions Treated With Kenalog Injections

  • Osteoarthritis, Rheumatoid Arthritis, and Gout
  • Bursitis and Tendonitis
  • Frozen Shoulder & Joint Capsule Inflammation
  • Carpal Tunnel Syndrome and Plantar Fasciitis
  • Chronic Back, Neck, or Sciatic Nerve Pain
  • Allergic Reactions (Severe Hay Fever, Asthma Flare-Ups)
  • Psoriasis, Eczema, and Other Skin Disorders
  • Keloid and Hypertrophic Scar Reduction

Kenalog injection is an injectable form of the corticosteroid triamcinolone (brand Kenalog). It is used by doctors to quickly dampen severe inflammation or allergic reactions in joints, skin, respiratory tract, and other tissues. It’s a prescription medication given by needle, not a home-use product.

FAQs for Kenalog Injections (Triamcinolone Acetonide) – Corticosteroid Solution for Inflammation, Joint Pain & Allergy Relief

  • What is a Kenalog Injection Used For?

    Kenalog injection is used for powerful anti-inflammatory relief in various conditions including: Arthritis & Joint Pain: Osteoarthritis, rheumatoid arthritis, bursitis, tendonitis, and synovitis. Allergic Reactions: Severe allergies, asthma, hay fever, and allergic rhinitis. Skin Disorders: Eczema, dermatitis, psoriasis. Other Inflammatory Conditions: Keloids, ulcerative colitis, and inflammatory eye diseases.

  • Is a Kenalog Shot the Same as a Cortisone Shot?

    Yes, Kenalog (triamcinolone) is a type of cortisone shot (corticosteroid injection), providing potent anti-inflammatory effects for rapid pain and swelling reduction.

  • Can You Have Kenalog Injection When Pregnant?

    Kenalog injections should be used with caution during pregnancy. Only administer if clearly needed and prescribed by a doctor, as corticosteroids may affect fetal development.

  • What Are the Disadvantages of Kenalog?

    Potential cons include: Risk of side effects like swelling, high blood pressure, and mood changes May cause skin thinning, infection, or slow wound healing at injection site Not suitable for long-term or frequent use due to systemic steroid effects

  • What Should I Avoid While Taking Kenalog?

    Avoid live vaccines (risk of infection) Limit exposure to sick people (immunosuppression risk) Alcohol (may worsen side effects) High-sugar, high-sodium foods (may enhance steroid side effects)

  • Are Kenalog Injections Worth It?

    Many patients report significant relief from joint pain, swelling, allergic reactions, and skin inflammation. The effectiveness depends on your condition and medical history.

  • Is Kenalog Better Than Prednisone?

    Both are corticosteroids, but Kenalog is injected for local, long-lasting effect, while Prednisone is taken orally for systemic impact. Doctor will choose based on your specific needs.

  • How Much Does a Kenalog Injection Cost?

    Prices range from $40 to $250 per shot in the USA, depending on dosage, administration site, and healthcare provider.

  • How Long Does a Kenalog Shot Stay in Your System?

    Kenalog’s effects can last several weeks to over a month. The medication is typically cleared in 2-5 weeks, but relief may persist.

  • Who Should Not Have Kenalog?

    Patients with fungal infections, uncontrolled diabetes, or active infections Individuals allergic to triamcinolone or other corticosteroids Those with osteoporosis, peptic ulcers, or certain glaucoma types (use with caution)

  • How Quickly Does Kenalog Work?

    Results are often noticeable within 24 to 48 hours, with peak relief in a few days. Efficacy varies based on injection site and condition.

  • Can Kenalog Cause Weight Gain?

    Yes, long-term use or high dosages of Kenalog (and other steroids) can contribute to increased appetite, water retention, and weight gain.

  • What is an Alternative to Kenalog?

    Other corticosteroid injections (methylprednisolone, dexamethasone) Oral steroids (Prednisone) NSAIDs, hyaluronic acid, biologics, or alternative therapies depending on your condition

  • What is the Aftercare for a Kenalog Injection?

    Rest the injection site for 24 hours Keep the area clean and dry Monitor for redness, swelling, or infection Apply ice packs for discomfort (if needed) Avoid heavy exercise at the site briefly

  • Is a Kenalog Shot Bad For You?

    Kenalog is safe when used as prescribed by a medical professional. However, repeated or high-dose injections increase risks of side effects, so always follow dosing guidance.

  • Can I Shower After Kenalog Injections?

    Yes, you can shower after the injection once any bleeding stops. Avoid soaking in tubs or pools for 24 hours post-injection.

  • Can I Take Ibuprofen With Kenalog?

    Generally yes, but always check with your doctor. Both can increase your risk of stomach issues, so use caution with chronic use.

  • When Should I Get a Kenalog Injection?

    Kenalog is recommended when conservative treatment hasn’t relieved inflammation, swelling, or allergic symptoms in joints, skin, or airways.

  • What is the Best Site for a Kenalog Injection?

    Intra-articular (directly into a joint): for arthritis Intramuscular (in the buttock, thigh, or deltoid): for systemic relief Intralesional (into skin lesions): for dermatologic or keloid treatment Your doctor determines the most effective site for your condition.

  • What is the Most Potent Corticosteroid Injection?

    Dexamethasone and betamethasone are considered highly potent steroids, but Kenalog (triamcinolone acetonide) is one of the strongest commonly used for joint, skin, and allergy issues.

  • How Long Can You Use Kenalog For?

    Typically, only a few injections per year are recommended to reduce side effect risks. Chronic use carries higher risks—always follow medical guidelines.

  • What Are the Cons of Kenalog Injection?

    Potential for infection, skin thinning, tendon rupture, high blood pressure, mood swings, and elevated blood sugar Not a cure—manages symptoms only

  • How Many Times a Year Can You Get a Kenalog Shot?

    Usually no more than 3-4 injections per year at the same site to avoid tissue damage and systemic steroid effects.

  • Is Kenalog Bad for Your Liver?

    Rarely, but in high doses or long-term use, corticosteroids can affect liver function. Always check liver enzymes if you have a history of liver disease.

  • Why Choose Kenalog (Triamcinolone) Injection?

    Highly effective anti-inflammatory and allergy relief Long-lasting pain and swelling reduction Trusted by doctors for joint, skin, and allergic conditions Proven safety when administered by professionals FDA-approved and strictly regulated

Get Notified When Back in Stock